Comparing orange or apple juice to water during labour in women with mild gestational diabetes

ISRCTN ISRCTN88883233
DOI https://doi.org/10.1186/ISRCTN88883233
Submission date
28/02/2023
Registration date
06/03/2023
Last edited
06/03/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Gestational diabetes is very common, affecting about 20% of pregnancies. About 80-90% of gestational diabetes is mild and women need only pay attention to their diet to control their blood sugar. Drinking during labour is safe. Many women prefer to drink sugar (energy) containing beverages during labour. There are some data to suggest that drinking energy-containing beverages in labour or just before Caesarean birth may improve birth and recovery-related outcomes. This study aims to compare drinking beverages containing carbohydrates compared to plain water only during labour in women with mild gestational diabetes whose blood sugars are controlled by diet, to evaluate its impact on the baby’s umbilical cord artery blood pH. The umbilical cord artery blood pH is an indicator of the baby's metabolic (general) well-being at birth.

Who can participate?
Labouring adult women who have gestational diabetes

What does the study involve?
Participants will be randomised to water or carbohydrate beverages (orange or apple juice) as oral fluids during their labour. The beverages will be given to women once they are in labour for them to drink, as much of and as often as they prefer. The primary outcome of the study is to evaluate the comparative effectiveness of these beverages on the baby’s umbilical cord artery blood pH taken after delivery. The umbilical cord artery blood pH is an all-round indicator of baby wellbeing. In addition, a number of secondary mother and baby outcomes will also be evaluated including blood sugar in labour, time to delivery, mode of delivery, blood loss at delivery, mothers’ satisfaction with their allocated beverage and baby outcomes like baby condition at birth (Apgar score), blood sugar after birth and admission to a baby ward.

What are the possible benefits and risks of participating?
The study expects to find that sugar-containing beverages (orange or apple juice) consumed during their labour by women with mild gestational diabetes that only needed diet to control, will not be harmful to the baby or the mother. Hence these women need not be restricted from drinks with sugar in labour. It is plausible that sugar-containing beverages in providing energy compared to plain water may enhance women’s labour.

The possible benefits of participation are that drinking juice (energy-containing fluid) during labour may improve participants’ labour performance. Fewer issues may be associated with low blood sugar during labour for these women. Major complications are not anticipated. Juice drinks may cause blood sugar to increase beyond the normal range and necessitate additional blood sugar monitoring or treatment measures to achieve control. However, we do not expect the baby to be affected by these acute changes if indeed they occur.

Where is the study run from?
Universiti Malaya Medical Center (Malaysia)

When is the study starting and how long is it expected to run for?
October 2022 to April 2024

Who is funding the study?
Universiti Malaya Medical Center (Malaysia)

Who is the main contact?
1. Dr Siti Nurliana Mohd Dani, nurliana.dani@ummc.edu.my (Malaysia)
2. Prof Tan Peng Chiong, pctan@um.edu.my (Malaysia)
3. Dr Rahmah Saaid, rahmah@ummc.edu.my (Malaysia)

Contact information

Dr Siti Nurliana Mohd Dani
Principal Investigator

Affiliation Medical Officer Obstetrics and Gynaecology
Universiti Malaya Medical Center
University Malaya
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia

ORCiD logoORCID ID 0009-0008-0065-3059
Phone +6012 6228171
Email nurliana.dani@ummc.edu.my
Prof Peng Chiong Tan
Principal Investigator

Affiliation Consultant in Obstetrics and Gynaecology
Universiti Malaya Medical Center
University Malaya
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia

ORCiD logoORCID ID 0000-0001-8713-6581
Phone +603 79492049
Email pctan@um.edu.my
Dr Rahmah Saaid
Principal Investigator

Affiliation Consultant in Obstetrics and Gynaecology
Universiti Malaya Medical Center
University Malaya
Jalan Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia

ORCiD logoORCID ID 0000-0003-0971-7481
Phone +603 79492049
Email rahmah@ummc.edu.my

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeOther
Participant information sheet No available in web format, please use contact details to request a participant information sheet.
Scientific titleCarbohydrate containing beverage compared to water during labour in women with gestational diabetes mellitus: A randomised controlled trial
Study hypothesisWe hypothesize that carbohydrate beverages during labour for women with gestational diabetes on diet control only will not impair (non-inferior) neonatal cord artery blood pH
Ethics approval(s)Approved 23/02/2023, Medical Research and Ethics Committee (University Malaya Medical Centre, Kuala Lumpur, Malaysia; +603 7949 3209, +603 7949 2251; ummc-mrec@ummc.edu.my), ref: 20221228-11883
ConditionLabouring women with gestational diabetes mellitus on diet control only
InterventionParticipants will be randomised to water or carbohydrate beverages (orange or apple juice) as oral fluids during their labour.

Method of randomization
Randomization is done by opening the lowest number, sealed and opaque envelope that is available, assigned in strict order to the newest recruit. The randomization sequence will be generated using a random number generator in random blocks of 4 or 8 sequences, generated by an investigator who is not involved in recruitment and placed within the envelopes. Randomly allocated intervention of drinking carbohydrate drinks or water only will only be revealed after the opening of the numbered envelope following written consent to participate.

Intervention provider
The intervention providers are medical residents or postnatal ward nurses or midwives in our centre who will provide the appropriate drink as allocated for women to consume at their own pace

Modes of delivery
The allocated drink will be delivered by hand to the participants

Location of intervention
Labour ward, Universiti Malaya Medical Centre, Kuala Lumpur
Intervention typeSupplement
Primary outcome measureUmbilical cord arterial blood pH value measured using hospital electronic medical records at hospital discharge
Secondary outcome measuresNeonatal outcome (measured using hospital electronic medical records at hospital discharge):
1. Umbilical cord arterial blood base excess
2. APGAR score at 1 minute and 5 minutes
3. Newborn blood sugar within 4 hours of birth
4. Birth weight
5. Neonatal admission (and indication)
6. Neonatal hypoglycemia (clinical diagnosis)
7. Birth trauma
8. Hypoxic-ischemic encephalopathy
9. Sepsis

Maternal outcome (measured using hospital electronic medical records at hospital discharge):
1. Intrapartum capillary blood glucose
2. Use of insulin infusion in labour
3. Vomiting in labour
4. Epidural analgesia in labour
5. Time to delivery
6. Mode of delivery
7. Perineal injury
8. Estimated blood loss
9. Intensive care unit admission
Overall study start date01/10/2022
Overall study end date30/04/2024

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants128 participants
Participant inclusion criteria1. Gestational diabetes mellitus on diet control only (GDMA1)
2. In active labour (cervical dilatation 3cm and contraction 3 in 10 minutes)
3. Term (gestational age 37 weeks)
4. Aged 18 years old and over
5. Single baby
6. Baby is in head down position (cephalic presentation)
7. Baby’s condition (cardiotocograph) is reassuring
Participant exclusion criteria1. On antiglycaemic drug for diabetes mellitus
2. BMI > 40
3. Preeclampsia
4. Known major fetal malformations
5. Evidence of chorioamnionitis or other maternal infection
6. Medical instruction forbidding oral intake
7. Contraindication for vaginal birth
Recruitment start date13/03/2023
Recruitment end date01/04/2024

Locations

Countries of recruitment

  • Malaysia

Study participating centre

Universiti Malaya Medical Center
University Malaya
Jalan Profesor Diraja Ungku Aziz
Lembah Pantai
Kuala Lumpur
59100
Malaysia

Sponsor information

University Malaya Medical Centre
Hospital/treatment centre

Jln Profesor Diraja Ungku Aziz
Kuala Lumpur
59100
Malaysia

Phone +60379494422
Email ummc@ummc.edu.my
Website www.ummc.edu.my
ROR logo "ROR" https://ror.org/00vkrxq08

Funders

Funder type

University/education

Universiti Malaya
Government organisation / Universities (academic only)
Alternative name(s)
University of Malaya, University Malaya, Malayan University, UM
Location
Malaysia

Results and Publications

Intention to publish date01/12/2024
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available later

Editorial Notes

03/03/2023: Trial's existence confirmed by the Medical Research Ethics Committee of the University of Malaya Medical Centre (Malaysia).